SCHEMBL6115131

SCHEMBL6115131

O=S(=O)(OCOS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
MMP1 P03956 1/20 0.54
MMP2 P08253 1/20 0.54
MMP9 P14780 1/20 0.54
MMP8 P22894 1/20 0.54
MMP13 P45452 1/20 0.54
HTT P42858 1/20 0.47
NR3C1 P04150 1/20 0.46
PGR P06401 1/20 0.46
AR P10275 1/20 0.46
ESR2 Q92731 1/20 0.46
TSHR P16473 2/20 0.45
CES2 O00748 1/20 0.44
AKR1B1 P15121 1/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31425773 0.84 CA1 (0.59) CA1CA2MMP1MMP2MMP9
SCHEMBL11351246 0.83 CA1 (0.48) CA1CA2MMP1MMP2MMP9
SCHEMBL13290866 0.81 CA1 (0.56) CA1CA2MMP1MMP2MMP9
SCHEMBL11350801 0.78 CA1 (0.43) CA1CA2MMP1MMP2MMP9
SCHEMBL6114563 0.78 PTGS2 (0.50) CA1CA2MMP1KMT2AALDH1A1
SCHEMBL30859041 0.77 CA1 (0.65) CA1CA2MMP1MMP2MMP9
SCHEMBL8863056 0.77 CA1 (0.65) CA1CA2MMP1MMP2MMP9
SCHEMBL11434551 0.77 CA1 (0.43) CA1CA2MMP1MMP2MMP9
SCHEMBL5400963 0.77 CA1 (0.51) CA1CA2MMP1MMP2MMP9
SCHEMBL5005253 0.76 NPSR1 (0.56) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2821395-B1 Novel disulfonic acid ester as an additive for an electrolyte for a lithium secondary battery WAKO PURE CHEM IND LTD (JP) 2017-06-21 EP disclosed
EP-2821395-A2 Novel disulfonic acid ester as an additive for an electrolyte for a lithium secondary battery Wako Pure Chemical Industries, Ltd. (JP) 2015-01-07 EP disclosed
US-8716513-B2 Process for production of bis-quaternary ammonium salt, and novel intermediate WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2014-05-06 US disclosed
EP-2463266-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE Wako Pure Chemical Industries, Ltd. (JP) 2012-06-13 EP disclosed
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE ASS1, C1S, FHIT CA1 163/4885CA2 83/4885MMP1 4095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.